273 related articles for article (PubMed ID: 27837603)
1. Current trends in clinical genetics of colorectal cancer.
Markovic S; Dimitrijevic I; Zogovic B; Markovic V; Barisic G; Krivokapic Z
J BUON; 2016; 21(5):1042-1049. PubMed ID: 27837603
[TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular features of young-onset colorectal cancer.
Ballester V; Rashtak S; Boardman L
World J Gastroenterol; 2016 Feb; 22(5):1736-44. PubMed ID: 26855533
[TBL] [Abstract][Full Text] [Related]
3. Clinical genetics of hereditary colorectal cancer.
Power DG; Gloglowski E; Lipkin SM
Hematol Oncol Clin North Am; 2010 Oct; 24(5):837-59. PubMed ID: 20816577
[TBL] [Abstract][Full Text] [Related]
4. The changing approach for identifying hereditary colorectal cancer syndromes.
Laghi L; Ricciardiello L
Nat Rev Gastroenterol Hepatol; 2020 Oct; 17(10):593-594. PubMed ID: 32651554
[No Abstract] [Full Text] [Related]
5. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents.
Bodo S; Colas C; Buhard O; Collura A; Tinat J; Lavoine N; Guilloux A; Chalastanis A; Lafitte P; Coulet F; Buisine MP; Ilencikova D; Ruiz-Ponte C; Kinzel M; Grandjouan S; Brems H; Lejeune S; Blanché H; Wang Q; Caron O; Cabaret O; Svrcek M; Vidaud D; Parfait B; Verloes A; Knappe UJ; Soubrier F; Mortemousque I; Leis A; Auclair-Perrossier J; Frébourg T; Fléjou JF; Entz-Werle N; Leclerc J; Malka D; Cohen-Haguenauer O; Goldberg Y; Gerdes AM; Fedhila F; Mathieu-Dramard M; Hamelin R; Wafaa B; Gauthier-Villars M; Bourdeaut F; Sheridan E; Vasen H; Brugières L; Wimmer K; Muleris M; Duval A;
Gastroenterology; 2015 Oct; 149(4):1017-29.e3. PubMed ID: 26116798
[TBL] [Abstract][Full Text] [Related]
6. The evolution of our molecular understanding of colorectal cancer: what we are doing now, what the future holds, and how tumor profiling is just the beginning.
Dienstmann R; Salazar R; Tabernero J
Am Soc Clin Oncol Educ Book; 2014; ():91-9. PubMed ID: 24857065
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
Coppedè F; Lopomo A; Spisni R; Migliore L
World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
[TBL] [Abstract][Full Text] [Related]
8. Recent applications of chemosensitivity tests for colorectal cancer treatment.
Yoon YS; Kim JC
World J Gastroenterol; 2014 Nov; 20(44):16398-408. PubMed ID: 25469008
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer: from prevention to personalized medicine.
Binefa G; Rodríguez-Moranta F; Teule A; Medina-Hayas M
World J Gastroenterol; 2014 Jun; 20(22):6786-808. PubMed ID: 24944469
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in colorectal cancer genetics and diagnostics.
Cheah PY
Crit Rev Oncol Hematol; 2009 Jan; 69(1):45-55. PubMed ID: 18774731
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing hereditary colorectal cancer.
Gallagher DJ; Smith JD; Offit K; Stadler ZK
Clin Colorectal Cancer; 2010 Oct; 9(4):205-11. PubMed ID: 20920991
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.
De Mattia E; Cecchin E; Toffoli G
Drug Resist Updat; 2015 May; 20():39-70. PubMed ID: 26027741
[TBL] [Abstract][Full Text] [Related]
14. The genetics of hereditary colon cancer.
Rustgi AK
Genes Dev; 2007 Oct; 21(20):2525-38. PubMed ID: 17938238
[TBL] [Abstract][Full Text] [Related]
15. Genetics and Genetic Testing in Hereditary Colorectal Cancer.
Stoffel EM; Boland CR
Gastroenterology; 2015 Oct; 149(5):1191-1203.e2. PubMed ID: 26226567
[TBL] [Abstract][Full Text] [Related]
16. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
17. Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy.
Murcia O; Juárez M; Hernández-Illán E; Egoavil C; Giner-Calabuig M; Rodríguez-Soler M; Jover R
World J Gastroenterol; 2016 Apr; 22(13):3516-30. PubMed ID: 27053844
[TBL] [Abstract][Full Text] [Related]
18. Pathologists - The watchpersons for hereditary tumor syndromes.
Agaimy A; Wick MR
Semin Diagn Pathol; 2018 May; 35(3):153. PubMed ID: 29409667
[No Abstract] [Full Text] [Related]
19. Uncovering Hereditary Tumor Syndromes: Emerging Role of Surgical Pathology.
Agaimy A; Hartmann A
Semin Diagn Pathol; 2018 May; 35(3):154-160. PubMed ID: 29395463
[TBL] [Abstract][Full Text] [Related]
20. Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia.
Molloy MP; Engel A
Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1179-1181. PubMed ID: 30791786
[No Abstract] [Full Text] [Related]
[Next] [New Search]